Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Vedistry launches Fortyfitt Woman Tablets
The tablets are packed with the potent combination of Soya phytoestrogens and nutraceuticals like green tea, ginseng, grape seed,…
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology
Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to Pfizer with…
BioNTech expects Omicron-adapted vaccine deliveries as soon as October
Demand for the vaccine, 3.6 billion doses of which have been shipped globally, is waning as most people in the Western world have…
Datwyler to double capacity at its Indian facility
Datwyler is increasing capacity for all three of its production standards in Pune. The expansion will nearly double capacity and…
CSIR gets first woman Director General in N Kalaiselvi
Known for her work in the field of lithium ion batteries, Kalaiselvi is at present Director of the CSIR-Central Electrochemical…
AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer…
MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop resistance to targetted therapy
Lilly’s Taltz now available in new, citrate-free formulation to reduce injection site pain
Since the medicine's first approval in 2016, nearly 130,000 people in the US have been treated with Taltz
Pharma operations: Easing margin pressure by releasing value from operations
Achal Saran Pande, Partner, Vector Consulting Group, discusses how the crux of preventing capacity wastage lies in understanding…
Aleor Dermaceuticals receives US FDA final approval for Adapalene and Benzoyl Peroxide Topical Gel,…
The approved ANDA is therapeutically equivalent to the Reference Listed Drug product (RLD) Epiduo Forte Topical Gel, 0.3%/2.5%, of…
Cipla betting big on digitisation and emerging segments
The drugmaker is also bullish on maximising value opportunity in the complex generics in the US market
China’s Innovent Biologics secures over $300 million investment from Sanofi
The all-cash investment by Sanofi unit Sanofi Foreign Participations BV will be at a price of $42.42 per Innovent share,…
Amgen says Lumakras plus immunotherapy for lung cancer needs further study
The findings are the first indication of how well Lumakras works in combination with drugs that help the immune system attack…
Biocon Sdn Bhd enters Malaysia Book of Records
The 562,000 sq ft facility has been recognised as the first and largest integrated insulin manufacturer in Malaysia by MBR
Amgen bets on ChemoCentryx’s rare disease drug in $3.7 billion deal
Amgen has been facing stiff competition for its top-selling arthritis drug, Enbrel, from newer branded treatments and patents for…
Streamlining pharma ecosystem of India with Saveo Healthtech
Shivansh Shrivastava, Co-founder, Saveo Healthtech talks to Cherish Mundhra, about the need to streamline the fragmented…
Pfizer to discontinue development programme for PF-07265803 for LMNA-related dilated cardiomyopathy
Decision follows results of interim futility analysis which indicate phase-III REALM-DCM trial unlikely to meet primary endpoint
EU approves AstraZeneca’s Lynparza for patients with germline BRCA-mutated HER2-negative…
It is the first and only approved medicine targetting BRCA mutations in early breast cancer
Identifying Chandigarh’s potential
Pharma experts and leaders at the Chandigarh Pharma Summit 2022 reflected upon and discussed key issues that will help the…
Zydus receives final approval from US FDA for Ivermectin cream
The cream is used for the treatment of inflammatory lesions of rosacea